| Old Articles: <Older 30441-30450 Newer> |
|---|
 |
The Motley Fool
May 30, 2008
Brian Lawler |
Bristol-Myers' Cheap Pipeline Bet Bristol-Myers announces that it is acquiring development-stage drugmaker Kosan Biosciences for a net price of $190 million in cash.   |
The Motley Fool
May 30, 2008
David Lee Smith |
Mother Russia's Mounting Metals March Russian tycoons are trying to merge into existence a major global player in mining and metals. |
The Motley Fool
May 30, 2008
Rick Aristotle Munarriz |
A Smart Bet on China's Stock Market Now that investing in China is more a learned art than a mania, where things such as valuations and fundamentals actually matter, the appeal of China Finance Online's Stockstar.com website is greater than ever. |
The Motley Fool
May 30, 2008
David Lee Smith |
Has Housing Turned? Yikes! Look at the builders' recent share-price performances. |
The Motley Fool
May 30, 2008
Brian Lawler |
Gilead Gets Synergistic Gilead Sciences newly acquired compound will play nicely with the drugmaker's existing products. |
The Motley Fool
May 30, 2008
Rich Duprey |
Does Heinz Have the Secret Sauce to Growth? H.J. Heinz has plans over the next two years to offer 400 new products. |
The Motley Fool
May 30, 2008
Dan Caplinger |
10 Stocks for a Scary Market These companies have stood the test of time. |
The Motley Fool
May 30, 2008
Christopher Barker |
A Quick Look at 5 Dry Bulk Shippers Dry bulk shippers are staying afloat. |
The Motley Fool
May 30, 2008
Rich Duprey |
Fred's No Longer a Retread? The discount retailer sees sales rise, but "strategic alternatives" still are on the table. |
The Motley Fool
May 30, 2008
Rich Greifner |
Is This the Bottom? Who Cares! A lesson in why timing the market is a bad idea. |
| <Older 30441-30450 Newer> Return to current articles. |
